Drugs / D-isoascorbic Acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05721872 | Feb → Aug 2023 | colorectal cancer | Nazarbayev University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D-isoascorbic Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05721872 ↗ |
| Known as | D-VC | “D-isoascorbic acid (D-VC) with a single intravenous injection” NCT05721872 ↗ |
| Route | Intravenous | “D-isoascorbic acid (D-VC) intravenously once a day” NCT05721872 ↗ |